211 - Ozempic for Everyone? The Problem With Targeting Young Women

GLP-1 medications like Ozempic and Wegovy are being marketed everywhere - but who’s really being targeted and who's benefitting? Today, we’re pulling back the curtain on how these drugs are promoted to the two most vulnerable groups when it comes to disordered eating: young women and menopausal women.We dig into:Why eating disorders are already surging in teens and women in their 20s.How menopause creates a “second wave” of vulnerability and disordered eatingThe role influencers and social media play in normalizing prescriptions as lifestyle upgrades and why affiliate marketing makes this dangerous.Then, we pivot gears to talk about the changing seasons of life. Summer is ending, kids are back to school, and routines are shifting. This doesn’t mean starting over - it means adapting your habits to the new season. Whether you’re concerned about the rise of diet culture and influencers profiting from your health and insecurities or you just need help navigating your own health pivot as seasons change, this episode cuts through the crap and helps you keep moving forward.Join our Patreon for monthly workouts, challenges, recipes, and to become part of the Cut The Crap Community! Become a member today for exclusive content and to support our podcast: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.patreon.com/cutthecrappodcast⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Thank you Cured Nutrition for sponsoring our Podcast! Just for our listeners, you can receive big savings by using our code 'CTC' when you purchase any Cured product! Pick up some serenity gummies to help you unwind at the end of a long day, flow gummies to help you crush your workout, or even some Salve to help soothe your sore muscles after an intense workout. ⁠Follow the pod: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@cutthecrapwithbethandmatt⁠⁠⁠⁠⁠⁠Follow your hosts:Beth: ⁠⁠⁠⁠⁠⁠@bethferacofitness⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Matt: ⁠⁠⁠⁠⁠⁠@mattlaarfit⁠⁠⁠⁠⁠⁠Send us a DM! Let us know what you think of this one, and with episode ideas! If we use your comment or suggestion, we'll give you a shoutout on the podcast!

There are no comments yet.

Please log in to write the first comment.